Abstract:Human Epidermal Growth Factor Receptor 2 (HER2) is an ideal target for anti-tumor drug development especially for breast cancer. Based on this target, either for new drug, bio-better, bio-similar screening at discovery level, or for drug substance and drug product release at QC or industry level, a reliable and robust biological potency assay is urgently needed. In this study, a BT-474 cell based anti-proliferation biological potency assay targeting HER2 was developed after an optimization of some key aspects,… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.